Jade Biosciences (JBIO) Capital Expenditures (2021 - 2025)

Jade Biosciences posted quarterly Capital Expenditures of $3000.0 for Q4 2025, down 98.31% on a QoQ basis from $177000.0 in Q3 2025.

Jade Biosciences (JBIO) has 4 years of Capital Expenditures data on file, last reported at $3000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures changed N/A year-over-year to $3000.0; the trailing twelve-month figure through Dec 2025 stood at $196000.0 (changed N/A YoY), and the FY2025 full-year result was $196000.0, changed N/A from the prior year.
  • Capital Expenditures for Q4 2025 stood at $3000.0, down from $177000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $177000.0 in Q3 2025 and bottomed at -$124000.0 in Q3 2022.
  • The 4-year median for Capital Expenditures is $30000.0 (2023), against an average of $47600.0.
  • The widest annual swing landed in 2022, when Capital Expenditures slumped 1966.67%; it then jumped 114.52% in 2023.
  • A 4-year view of Capital Expenditures shows it stood at $147000.0 in 2021, then grew by 9.52% to $161000.0 in 2022, then plunged by 51.55% to $78000.0 in 2023, then plunged by 96.15% to $3000.0 in 2025.
  • The last three Capital Expenditures figures came in at $3000.0 (Q4 2025), $177000.0 (Q3 2025), and $11000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 133.40 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 230.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 21.83 Mn
10 Jade Biosciences 1.06 Bn 1.06 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3,000.00
Dec 31, 2025 3,000.00
Sep 30, 2025 177,000.00
Sep 30, 2025 177,000.00
Jun 30, 2025 11,000.00
Jun 30, 2025 11,000.00
Mar 31, 2025 5,000.00
Mar 31, 2025 5,000.00
Dec 31, 2023 78,000.00
Dec 31, 2023 78,000.00
Sep 30, 2023 18,000.00
Sep 30, 2023 18,000.00
Jun 30, 2023 16,000.00
Jun 30, 2023 16,000.00
Mar 31, 2023 30,000.00
Mar 31, 2023 30,000.00
Dec 31, 2022 161,000.00
Dec 31, 2022 161,000.00
Sep 30, 2022 -124,000.00
Sep 30, 2022 -124,000.00
Jun 30, 2022 73,000.00
Jun 30, 2022 73,000.00
Mar 31, 2022 85,000.00
Mar 31, 2022 85,000.00
Dec 31, 2021 147,000.00
Dec 31, 2021 147,000.00
Sep 30, 2021 -6,000.00
Sep 30, 2021 -6,000.00
Mar 31, 2021 40,000.00
Mar 31, 2021 40,000.00